 |
 |
|
|
|
| Dasatinib|302962-49-8 |
 |
| 99% |
 |
| 302962-49-8 |
 |
Leukemia
|
 |
Dasatinib [CAS:302962-49-8]
Intermediates:
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide [CAS:302964-24-5]
2-[(6-Chloro-2-methylpyrimidin-4-yl)amino]-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide [CAS:302964-08-5]
Usage:Leukemia
|
| Industrial field |
pharmaceutical |
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
